Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joan Schiller

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
BMJ Oncology|April 1, 2025
Air pollution and its impact on cancer incidence, cancer care and cancer outcomesRoselle De Guzman, Joan Schiller
Journal of the National Cancer Institute|October 19, 2017
ResponseLorraine Pelosof, Chul Ahn, Joan Schiller
Cancer Chemotherapy and Pharmacology|February 29, 2008
A phase I study of gemcitabine plus palliative radiation therapy for advanced lung cancerBrian Choi, H Ian Robins, Joan Schiller, et al.
Lung Cancer (Amsterdam, Netherlands)|November 7, 2006
Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical researchChandra P Belani, Sherry Marts, Joan Schiller, et al.
Clinical Journal of Oncology Nursing|January 24, 2022
Climate Change and Oncology Nursing: A Call to ActionErin Dickman, Chelsea Backler, Christine D Berg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Spiral computed tomography and lung cancer: science, the media, and public opinionRobert A Schnoll, E Paul Wileyto, Robert Hornik, et al.
Lung Cancer (Amsterdam, Netherlands)|December 31, 2003
Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in EuropeJoan Schiller, Dominic Tilden, Michael Aristides, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell lung cancer patients: ECOG 1599Corey Langer, Sigui Li, Joan Schiller, et al.
JTO Clinical and Research Reports|March 14, 2022
Bevacizumab's Association With a Decreased Risk of Brain Metastases in ECOG-ACRIN E1505, a Phase 3 Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab in Surgically Resected NSCLCJohn M Varlotto, Yating Wang, Zhuoxin Sun, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A phase II trial of carboplatin and gemcitabine with exisulind (IND #65,056) in patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (E1501)Gregory A Masters, Sigui Li, Afshin Dowlati, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
BMJ Oncology|April 1, 2025
Air pollution and its impact on cancer incidence, cancer care and cancer outcomesRoselle De Guzman, Joan Schiller
Journal of the National Cancer Institute|October 19, 2017
ResponseLorraine Pelosof, Chul Ahn, Joan Schiller
Cancer Chemotherapy and Pharmacology|February 29, 2008
A phase I study of gemcitabine plus palliative radiation therapy for advanced lung cancerBrian Choi, H Ian Robins, Joan Schiller, et al.
Lung Cancer (Amsterdam, Netherlands)|November 7, 2006
Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical researchChandra P Belani, Sherry Marts, Joan Schiller, et al.
Clinical Journal of Oncology Nursing|January 24, 2022
Climate Change and Oncology Nursing: A Call to ActionErin Dickman, Chelsea Backler, Christine D Berg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Spiral computed tomography and lung cancer: science, the media, and public opinionRobert A Schnoll, E Paul Wileyto, Robert Hornik, et al.
Lung Cancer (Amsterdam, Netherlands)|December 31, 2003
Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in EuropeJoan Schiller, Dominic Tilden, Michael Aristides, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Randomized phase II trial of paclitaxel plus carboplatin or gemcitabine plus cisplatin in Eastern Cooperative Oncology Group performance status 2 non-small-cell lung cancer patients: ECOG 1599Corey Langer, Sigui Li, Joan Schiller, et al.
JTO Clinical and Research Reports|March 14, 2022
Bevacizumab's Association With a Decreased Risk of Brain Metastases in ECOG-ACRIN E1505, a Phase 3 Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab in Surgically Resected NSCLCJohn M Varlotto, Yating Wang, Zhuoxin Sun, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A phase II trial of carboplatin and gemcitabine with exisulind (IND #65,056) in patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (E1501)Gregory A Masters, Sigui Li, Afshin Dowlati, et al.
Pageof 4